Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dardo Riveros is active.

Publication


Featured researches published by Dardo Riveros.


PLOS ONE | 2016

Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies.

Nora P. Goette; Ana C. Glembotsky; Paola R. Lev; Matías Grodzielski; Geraldine Contrufo; Marta S. Pierdominici; Yesica Romina Espasandin; Dardo Riveros; Alejandro J. García; Felisa C. Molinas; Paula G. Heller; Rosana F. Marta

Mechanisms leading to decreased platelet count in immune thrombocytopenia (ITP) are heterogeneous. This study describes increased platelet apoptosis involving loss of mitochondrial membrane potential (ΔΨm), caspase 3 activation (aCasp3) and phosphatidylserine (PS) externalization in a cohort of adult ITP patients. Apoptosis was not related to platelet activation, as PAC-1 binding, P-selectin exposure and GPIb-IX internalization were not increased. Besides, ITP platelets were more sensitive to apoptotic stimulus in terms of aCasp3. Incubation of normal platelets with ITP plasma induced loss of ΔΨm, while PS exposure and aCasp3 remained unaltered. The increase in PS exposure observed in ITP platelets could be reproduced in normal platelets incubated with ITP plasma by adding normal CD3+ lymphocytes to the system as effector cells. Addition of leupeptin -a cathepsin B inhibitor- to this system protected platelets from apoptosis. Increased PS exposure was also observed when normal platelets and CD3+ lymphocytes were incubated with purified IgG from ITP patients and was absent when ITP plasma was depleted of auto-antibodies, pointing to the latter as responsible for platelet damage. Apoptosis was present in platelets from all patients carrying anti-GPIIb-IIIa and anti-GPIb auto-antibodies but was absent in the patient with anti-GPIa-IIa auto-antibodies. Platelet damage inversely correlated with platelet count and decreased during treatment with a thrombopoietin receptor agonist. These results point to a key role for auto-antibodies in platelet apoptosis and suggest that antibody-dependent cell cytotoxicity is the mechanism underlying this phenomenon.


Revista De Calidad Asistencial | 2007

Calidad asistencial y prevención de enfermedad tromboembólica venosa. Nuevo modelo de gestión

Jorge Orosco Pedemonte; Patricio Duarte; Beatriz Grand; Dardo Riveros; José Antonio Mirón Canelo

Resumen Uno de los objetivos de cualquier programa de salud debe ser alcanzar un alto grado de calidad asistencial, y para ello se debe tener en cuenta conceptos como nivel cientifico-tecnico, eficacia, efectividad, eficiencia, adecuacion, continuidad, accesibilidad, satisfaccion del usuario y otros como solidaridad, equidad y etica. Para cualquier plan de mejora de la calidad que se quiera implementar es importante la activa participacion de los profesionales. Por tal motivo se ha formado un nuevo modelo de gestion que se basa en pequenas unidades o grupos compuestos por los profesionales, y cuyas funciones son la planificacion, la ejecucion, el control y la evaluacion de las diversas actividades que se desprenden de un determinado proceso asistencial, tales como las relacionadas con la docencia, la investigacion, la gestion y la asistencia (grupos DIGA). En el presente estudio, uno de los grupos formados se encarga de las acciones de mejora del proceso asistencial prevencion de la enfermedad tromboembolica venosa (PETEV), para el que hay una gran variedad de criterios terapeuticos, por lo que resulta fundamental conocer que es lo que se hace, como se hace y cuales son los resultados alcanzados. Por tal motivo, el grupo de profesionales confecciona una guia con recomendaciones para la PETEV, participa en su difusion, y se encarga de implementar la medicion de los resultados y su posterior evaluacion y aplicacion. Dichos resultados muestran el grado de calidad alcanzado en el proceso asistencial en cuestion, y permiten detectar rapidamente situaciones de baja calidad, para tratar de revertirlas lo mas rapidamente posible y, de esa forma, garantizar la calidad.


Cancer Genetics and Cytogenetics | 2005

Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events

Patricia Gargallo; Roberto Cacchione; Christian Chena; Juan Dupont; Guy Garay; Dardo Riveros; Irene Larripa; Irma Slavutsky


Medicina-buenos Aires | 2006

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.

Juan M. Rodríguez; Fernanda Elı́as; Alejandro Montaner; Juan Fló; Ricardo A. López; Jorge Zorzopulos; Raul Franco; Silvina P. Lenial; Mariella López Salón; María L. Pirpignani; Jorge Solimano; Guy Garay; Dardo Riveros; José A. Fernández; Roberto Cacchione; Juan Dupont


Lymphatic Research and Biology | 2006

99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.

Alberto Lazarowski; Juan Dupont; José A. Fernández; Guy Garay; Alejo Florín; Jorge Solimano; Dardo Riveros; Roberto Cacchione


Blood | 2013

Ruxolitinib In Myelofibrosis (MF) Patients Through Compassionate Use Program (CUP). Argentinian Experience

María Jose Mela Osorio; Paula Barreyro; Alicia Enrico; Ana García de Labanca; Pedro Negri; Ana Inés Varela; Adriana Vitriu; Daniel Bär; Ricardo Benzadón; Rubén Burgos; Lucía Celebrín; José Ceresetto; Ariel Corzo; Isolda Fernandez; María Gabriela Flores; Ana Victoria Galeazzi; Emilio A Lanari Zubiaur; Felisa C. Molinas; Sergio Orlando; Miguel A. Pavlovsky; Guillermina Remaggi; Dardo Riveros; Silvia Rudoy; Gustavo Taborda; Julio Sánchez Avalos; Federico Sackmann; Raquel Bengió


Blood | 2014

Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment

Geraldine Contrufo; Ana C. Glembotsky; Nora P. Goette; Paola R. Lev; Matías Grodzielski; Marta S. Pierdominici; Dardo Riveros; Verónica Susana Montero; Alejandro J. García; Felisa C. Molinas; Paula G. Heller; Rosana F. Marta


American Journal of Obstetrics and Gynecology | 1990

Laboratory identification of the lupus anticoagulant in normal pregnancy and pregnancy-induced hypertension

Dardo Riveros; Beatriz Grand; Alicia N. Blanco; Graciela Pieroni; Maria A. Lazzari; Liliana S. Voto


Arthritis & Rheumatism | 1988

Lupus anticoagulant,anti-ro (ss-a) antibodies, and fetal wastage in system lupus erythematosus

Osvaldo Hübscher; Alicia Eimon; Arana Rm; Dardo Riveros


Blood | 2017

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Florencia Negri Aranguren; Santiago Cranco; Claudia Shanley; Isolda Fernandez; Maria Virginia Prates; Victoria Otero; Lorena Fiad; Maria Cecilia Foncuberta; Marcela Miodosky; Miguel A. Pavlovsky; Gustavo Kuminsky; Javier Bordone; Bruno Wannesson; Ariel Corso Corso; Dardo Riveros; Marisa Marquez; Gustavo Jarchum; Maria Sol Jarchum; Ider Cerutti; Alicia Bistmas; Monica Tamashiro; Giselda De Stefano; Alicia Navieckas; Silvana Cugliari; Pedro Negri Aranguren; Gabriela Balaguer; Maria Tosin; Guillermina Remaggi; Juan Altuve; Juan José García García

Collaboration


Dive into the Dardo Riveros's collaboration.

Top Co-Authors

Avatar

Juan Dupont

New York Academy of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Beatriz Grand

Academia Nacional de Medicina

View shared research outputs
Top Co-Authors

Avatar

Jorge Milone

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Felisa C. Molinas

University of Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Luis Palmer

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge